ADVENT Post Approval Study

计划入组 228 人 · 首次发布于 2024 年 5 月 29 日

ADVENT Trial Long Term Outcomes Evaluating Atrial Fibrillation Progression Study

计划入组 356 人 · 首次发布于 2024 年 7 月 30 日

Exacerbations and Their Outcomes International (EXACOS International)

计划入组 1,762 人 · 首次发布于 2021 年 6 月 16 日

Venezuelan equine encephalitis VLP-based vaccine (SRI International/USAMRIID)

B2D (SRI International)

Trivalent vaccine (Baxter international)

Advent Claymore Convt Security & Income Fund

Advanz Pharma International LIMITED

Ireland

GALDERMA INTERNATIONAL

France

Advent International Invests $175 Million in Animal Health Generics Company Felix Pharmaceuticals

Simtra BioPharma Solutions Completes Major Facility Expansion in Germany to Meet Growing Injectable Therapeutics Demand

Northwest Biotherapeutics Completes Strategic Acquisition of Advent BioServices to Integrate Manufacturing Operations